{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:38:13Z","timestamp":1794865093604,"version":"4.9.1"},"reference-count":213,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/002149"],"award-info":[{"award-number":["CRG\/2022\/002149"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"DBT\/Wellcome Trust India Alliance","doi-asserted-by":"publisher","award":["IA\/I\/16\/2\/502691"],"award-info":[{"award-number":["IA\/I\/16\/2\/502691"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.livres.2024.03.002","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T02:29:35Z","timestamp":1710210575000},"page":"34-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Targeting nuclear receptors for NASH\/MASH: From bench to bedside"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3408-070X","authenticated-orcid":false,"given":"Rohit A.","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2024.03.002_bib1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.gtc.2019.09.005","article-title":"Implications of nonalcoholic steatohepatitis as the cause of end-stage liver disease before and after liver transplant","volume":"49","author":"Chandrakumaran","year":"2020","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.livres.2024.03.002_bib4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.livres.2024.03.002_bib5","article-title":"NAFLD and liver transplantation: disease burden, current management and future challenges","volume":"2","author":"Burra","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2024.03.002_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.livres.2024.03.002_bib7","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2024.03.002_bib8","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3390\/cells12141845","article-title":"Targeting extracellular RNA mitigates hepatic lipotoxicity and liver injury in NASH","volume":"12","author":"Tewari","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.livres.2024.03.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101119","article-title":"Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease","volume":"50","author":"Xiao","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","article-title":"Nuclear receptors, RXR, and the big bang","volume":"157","author":"Evans","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.livres.2024.03.002_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2023.111884","article-title":"Special issue on non-genomic actions of nuclear receptors: an evolutionary and physiological perspective","volume":"564","author":"Arnal","year":"2023","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.livres.2024.03.002_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.livres.2024.03.002_bib13","article-title":"Cellular Action of Thyroid Hormone","author":"Sinha","year":"2018"},{"key":"10.1016\/j.livres.2024.03.002_bib14","first-page":"397","article-title":"Production of a specific polyclonal antibody against the rat beta thyroid receptor, using synthetic peptide as antigen","volume":"125","author":"Puymirat","year":"1991","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.livres.2024.03.002_bib15","doi-asserted-by":"crossref","first-page":"C1467","DOI":"10.1152\/ajpcell.00575.2006","article-title":"Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC\/IP(3)\/Ca(2+)-dependent downregulation of SRC\/ERK1\/2","volume":"292","author":"Fava","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.livres.2024.03.002_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.mce.2010.03.014","article-title":"Kupffer-cell activity is essential for thyroid hormone rat liver preconditioning","volume":"323","author":"Tapia","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.livres.2024.03.002_bib17","doi-asserted-by":"crossref","first-page":"S582","DOI":"10.1016\/S0168-8278(17)31587-8","article-title":"Thyroid hormone receptor regulates hepatic stellate cell activation","volume":"66","author":"Manka","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/abr.abr_15_21","article-title":"Association of subclinical hypothyroidism with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a cross-sectional study","volume":"11","author":"Sheikhi","year":"2022","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.livres.2024.03.002_bib19","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.14309\/ajg.0000000000000654","article-title":"Low thyroid function in nonalcoholic fatty liver disease is an independent predictor of all-cause and cardiovascular mortality","volume":"115","author":"Kim","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2024.03.002_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2017.08.014","article-title":"Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis","volume":"16","author":"Kim","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10620-011-2006-2","article-title":"Prevalence of hypothyroidism in nonalcoholic fatty liver disease","volume":"57","author":"Pagadala","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2024.03.002_bib22","doi-asserted-by":"crossref","first-page":"c7199","DOI":"10.1136\/bmj.c7199","article-title":"Hypothyroidism in a patient with non-alcoholic fatty liver disease","volume":"342","author":"Gardner","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.livres.2024.03.002_bib23","first-page":"149","article-title":"Fatigue in non-alcoholic fatty liver disease: is there a role for hypothyroidism","volume":"58","author":"Kalaitzakis","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.livres.2024.03.002_bib24","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1210\/en.2014-1302","article-title":"Repair-related activation of hedgehog signaling in stromal cells promotes intrahepatic hypothyroidism","volume":"155","author":"Bohinc","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.livres.2024.03.002_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.22572","article-title":"Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist","volume":"49","author":"Cable","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib26","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1096\/fj.08-108464","article-title":"Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit\/reverse nonalcoholic fatty liver in rats","volume":"22","author":"Perra","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.livres.2024.03.002_bib27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1089\/thy.2021.0621","article-title":"Thyroid hormone decreases hepatic steatosis, inflammation, and fibrosis in a dietary mouse model of nonalcoholic steatohepatitis","volume":"32","author":"Zhou","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.livres.2024.03.002_bib28","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/s41598-017-02205-1","article-title":"Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet","volume":"7","author":"Iannucci","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2024.03.002_bib29","first-page":"72","article-title":"The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD","volume":"7","author":"Zhou","year":"2021","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.livres.2024.03.002_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/er.2016-1103","article-title":"Reciprocal crosstalk between autophagic and endocrine signaling in metabolic homeostasis","volume":"38","author":"Sinha","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.livres.2024.03.002_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13578-016-0113-7","article-title":"Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD","volume":"6","author":"Sinha","year":"2016","journal-title":"Cell Biosci"},{"key":"10.1016\/j.livres.2024.03.002_bib32","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1172\/JCI60580","article-title":"Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy","volume":"122","author":"Sinha","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2024.03.002_bib33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/me.2008-0311","article-title":"Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms","volume":"23","author":"Araki","year":"2009","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.livres.2024.03.002_bib34","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1089\/thy.2020.0651","article-title":"Increased hepatic fat content in patients with resistance to thyroid hormone beta","volume":"31","author":"Chaves","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.livres.2024.03.002_bib35","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1210\/jc.2018-00475","article-title":"Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD","volume":"103","author":"Bruinstroop","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib36","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1210\/clinem\/dgad072","article-title":"Thyroid hormone receptor-\u03b2 agonists in NAFLD therapy: possibilities and challenges","volume":"108","author":"Li","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib37","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2024.03.002_bib38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep4.1657","article-title":"Effects of resmetirom on noninvasive endpoints in a 36-week phase 2 active treatment extension study in patients with NASH","volume":"5","author":"Harrison","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2024.03.002_bib39","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cgh.2021.07.039","article-title":"Hepatic fat reduction due to resmetirom in patients with nonalcoholic steatohepatitis is Associated with improvement of quality of life","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s41669-022-00370-2","article-title":"Early cost-effectiveness and price threshold analyses of resmetirom: an investigational treatment for management of nonalcoholic steatohepatitis","volume":"7","author":"Javanbakht","year":"2023","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/j.livres.2024.03.002_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A\u00a0phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2024.03.002_bib42","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1042\/BST20210419","article-title":"Structural insights into glucocorticoid receptor function","volume":"49","author":"Frank","year":"2021","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.livres.2024.03.002_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1101\/gr.212175.116","article-title":"Transcription factor assisted loading and enhancer dynamics dictate the hepatic fasting response","volume":"27","author":"Goldstein","year":"2017","journal-title":"Genome Res"},{"key":"10.1016\/j.livres.2024.03.002_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cmet.2008.08.001","article-title":"The glucocorticoid receptor controls hepatic dyslipidemia through Hes1","volume":"8","author":"Lemke","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jhep.2015.11.023","article-title":"Decreased expression of the glucocorticoid receptor-GILZ pathway in Kupffer cells promotes liver inflammation in obese mice","volume":"64","author":"Robert","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib46","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/DMSO.S247379","article-title":"Glucocorticoid-induced fatty liver disease","volume":"13","author":"Rahimi","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.livres.2024.03.002_bib47","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1200\/JCO.2005.10.036","article-title":"Estrogen-receptor biology: continuing progress and therapeutic implications","volume":"23","author":"Osborne","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.livres.2024.03.002_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.livres.2024.03.002_bib49","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1210\/me.2006-0012","article-title":"Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob\/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3","volume":"20","author":"Gao","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.livres.2024.03.002_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/me.2007-0121","article-title":"Genome-wide identification of estrogen receptor alpha-binding sites in mouse liver","volume":"22","author":"Gao","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.livres.2024.03.002_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1530\/JOE-10-0462","article-title":"A\u00a0selective estrogen receptor \u03b1 agonist ameliorates hepatic steatosis in the male aromatase knockout mouse","volume":"210","author":"Chow","year":"2011","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.livres.2024.03.002_bib52","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep4.1363","article-title":"Selective liver estrogen receptor \u03b1 modulation prevents steatosis, diabetes, and obesity through the anorectic growth differentiation factor 15 hepatokine in mice","volume":"3","author":"Guillaume","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2024.03.002_bib53","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ijo.2017.50","article-title":"Hormone signaling and fatty liver in females: analysis of estrogen receptor \u03b1 mutant mice","volume":"41","author":"Hart-Unger","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.livres.2024.03.002_bib54","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1152\/ajpendo.00259.2018","article-title":"Estrogen receptor-\u03b1 signaling maintains immunometabolic function in males and is obligatory for exercise-induced amelioration of nonalcoholic fatty liver","volume":"316","author":"Winn","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib55","doi-asserted-by":"crossref","first-page":"11806","DOI":"10.1073\/pnas.1205797109","article-title":"Tetradian oscillation of estrogen receptor \u03b1 is necessary to prevent liver lipid deposition","volume":"109","author":"Villa","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2024.03.002_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2022.01.085","article-title":"Estrogen receptor \u03b1 mediated M1\/M2 macrophages polarization plays a critical role in NASH of female mice","volume":"596","author":"Shu","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.livres.2024.03.002_bib57","doi-asserted-by":"crossref","first-page":"bqaa134","DOI":"10.1210\/endocr\/bqaa134","article-title":"NAFLD and NASH in Postmenopausal women: implications for diagnosis and treatment","volume":"161","author":"DiStefano","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.livres.2024.03.002_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejogrb.2015.04.017","article-title":"Menopausal stages and non-alcoholic fatty liver disease in middle-aged women","volume":"190","author":"Ryu","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.livres.2024.03.002_bib59","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gut.2006.115345","article-title":"Menopausal status and hepatic steatosis in a general female population","volume":"56","author":"V\u00f6lzke","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.livres.2024.03.002_bib60","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","article-title":"Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial","volume":"65","author":"McKenzie","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.livres.2024.03.002_bib62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmet.2019.12.009","article-title":"Hepatic ER\u03b1 accounts for sex differences in the ability to cope with an excess of dietary lipids","volume":"32","author":"Meda","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.prp.2013.04.010","article-title":"Presence and extent of estrogen receptor-alpha expression in patients with simple steatosis and NASH","volume":"209","author":"Erkan","year":"2013","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.livres.2024.03.002_bib64","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/1535370216688569","article-title":"An estrogen receptor \u03b2-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors","volume":"242","author":"Ponnusamy","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.livres.2024.03.002_bib65","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3390\/nu14142847","article-title":"Vitamin D and its receptor from a structural perspective","volume":"14","author":"Rochel","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2024.03.002_bib66","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/er.2018-00126","article-title":"Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions","volume":"40","author":"Bouillon","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.livres.2024.03.002_bib67","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1365-2362.2012.02706.x","article-title":"Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism","volume":"42","author":"Yin","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.livres.2024.03.002_bib68","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2010.11.028","article-title":"Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats","volume":"55","author":"Nakano","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.livres.2021.03.004","article-title":"Vitamins and non-alcoholic fatty liver disease: a molecular insight","volume":"5","author":"Raza","year":"2021","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2024.03.002_bib70","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jhep.2016.05.031","article-title":"Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis","volume":"65","author":"Bozic","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib71","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.ajpath.2018.07.028","article-title":"Angiopoietin-like protein 8 is a novel vitamin D receptor target gene involved in nonalcoholic fatty liver pathogenesis","volume":"188","author":"Garc\u00eda-Monz\u00f3n","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2024.03.002_bib72","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/liv.14554","article-title":"Relationship between hepatic and systemic angiopoietin-like 3, hepatic vitamin D receptor expression and NAFLD in obesity","volume":"40","author":"Barchetta","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2024.03.002_bib73","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","article-title":"A\u00a0vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response","volume":"153","author":"Ding","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.livres.2024.03.002_bib74","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1074\/jbc.RA119.011487","article-title":"Vitamin D receptor targets hepatocyte nuclear factor 4\u03b1 and mediates protective effects of vitamin D in nonalcoholic fatty liver disease","volume":"295","author":"Zhang","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2024.03.002_bib75","doi-asserted-by":"crossref","first-page":"bqab249","DOI":"10.1210\/endocr\/bqab249","article-title":"Adipose-specific VDR deletion leads to hepatic steatosis in female mice fed a low-fat diet","volume":"163","author":"Tao","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.livres.2024.03.002_bib76","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.bbadis.2019.03.007","article-title":"Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"key":"10.1016\/j.livres.2024.03.002_bib77","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/jhep.2003.50176","article-title":"The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells","volume":"37","author":"Gascon-Barr\u00e9","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib78","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.30937","article-title":"Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice","volume":"71","author":"Dong","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib79","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.3390\/ijms24098288","article-title":"Gene polymorphisms and biological effects of vitamin D receptor on nonalcoholic fatty liver disease development and progression","volume":"24","author":"Tourkochristou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2024.03.002_bib80","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.3390\/ijms23169122","article-title":"Vitamin D-related genetic variations and nonalcoholic fatty liver disease: a systematic review","volume":"23","author":"Jaroenlapnopparat","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2024.03.002_bib81","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/ijpo.12293","article-title":"Vitamin D status and associated genetic polymorphisms in a cohort of UK children with non-alcoholic fatty liver disease","volume":"13","author":"Gibson","year":"2018","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.livres.2024.03.002_bib82","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.dld.2018.12.022","article-title":"Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"51","author":"Arai","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.livres.2024.03.002_bib83","doi-asserted-by":"crossref","first-page":"T13","DOI":"10.1530\/JME-22-0097","article-title":"Retinoic acid receptors at 35 years","volume":"69","author":"Petkovich","year":"2022","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.livres.2024.03.002_bib84","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/1471-2164-14-575","article-title":"The role of retinoic acid in hepatic lipid homeostasis defined by genomic binding and transcriptome profiling","volume":"14","author":"He","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.livres.2024.03.002_bib85","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bcp.2014.08.018","article-title":"All-trans retinoic acid regulates hepatic bile acid homeostasis","volume":"91","author":"Yang","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.livres.2024.03.002_bib86","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.26699","article-title":"All-trans-retinoic acid ameliorates hepatic steatosis in mice by a novel transcriptional cascade","volume":"59","author":"Kim","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib87","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/hep.25798","article-title":"Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice","volume":"56","author":"Tsuchiya","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib88","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/dom.12590","article-title":"Retinoic acid receptor \u03b22 agonists restore glycaemic control in diabetes and reduce steatosis","volume":"18","author":"Trasino","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101331","article-title":"A\u00a0retinoic acid receptor \u03b22 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease","volume":"297","author":"Tang","year":"2021","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2024.03.002_bib90","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00109-016-1434-z","article-title":"A\u00a0retinoic acid receptor \u03b22 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease","volume":"94","author":"Trasino","year":"2016","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.livres.2024.03.002_bib91","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3945\/ajcn.114.105155","article-title":"Association of serum retinoic acid with hepatic steatosis and liver injury in nonalcoholic fatty liver disease","volume":"102","author":"Liu","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.livres.2024.03.002_bib92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/nu10010029","article-title":"Disturbed vitamin a metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"10","author":"Saeed","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2024.03.002_bib93","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2337\/db19-1001","article-title":"A\u00a0small molecule, UAB126, reverses diet-induced obesity and its associated metabolic disorders","volume":"69","author":"Ren","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.livres.2024.03.002_bib94","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3390\/ijms23052668","article-title":"Nuclear receptors linking metabolism, inflammation, and fibrosis in nonalcoholic fatty liver disease","volume":"23","author":"Puengel","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2024.03.002_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166235","article-title":"Nuclear receptors in liver fibrosis","volume":"1867","author":"K\u00f6nigshofer","year":"2021","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"key":"10.1016\/j.livres.2024.03.002_bib96","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jcmgh.2021.01.012","article-title":"Transcriptional regulation of metabolic pathways via lipid-sensing nuclear receptors PPARs, FXR, and LXR in NASH","volume":"11","author":"Cariello","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib97","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","article-title":"PPARs at the crossroads of lipid signaling and inflammation","volume":"23","author":"Wahli","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib98","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jhep.2023.07.004","article-title":"Treating NASH by targeting peroxisome proliferator-activated receptors","volume":"79","author":"Staels","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib99","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.3390\/ijms21072391","article-title":"Hepatic lipid catabolism via PPAR\u03b1-lysosomal crosstalk","volume":"21","author":"Sinha","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2024.03.002_bib100","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1074\/jbc.274.7.3970","article-title":"Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene","volume":"274","author":"Frohnert","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2024.03.002_bib101","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1073\/pnas.91.23.11012","article-title":"The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression","volume":"91","author":"Gulick","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2024.03.002_bib102","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","article-title":"PPARalpha is a key regulator of hepatic FGF21","volume":"360","author":"Lund\u00e5sen","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.livres.2024.03.002_bib103","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.livres.2024.03.002_bib104","doi-asserted-by":"crossref","first-page":"21466","DOI":"10.1074\/jbc.M110.209973","article-title":"Human SREBP1c expression in liver is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"286","author":"Fern\u00e1ndez-Alvarez","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2024.03.002_bib105","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI6223","article-title":"Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting","volume":"103","author":"Kersten","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2024.03.002_bib106","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/en.2007-1339","article-title":"Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-alpha control of the acute-phase response","volume":"149","author":"Mansouri","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.livres.2024.03.002_bib107","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/hep.20170","article-title":"Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice","volume":"39","author":"Ip","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib108","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.27297","article-title":"The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice","volume":"60","author":"Pawlak","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib109","doi-asserted-by":"crossref","first-page":"33471","DOI":"10.1074\/jbc.M102839200","article-title":"Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box\/enhancer-binding protein beta","volume":"276","author":"Gervois","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2024.03.002_bib110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib111","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/apt.16596","article-title":"Randomised clinical trial: pemafibrate, a novel selective peroxisome proliferator-activated receptor \u03b1 modulator (SPPARM\u03b1), versus placebo in patients with non-alcoholic fatty liver disease","volume":"54","author":"Nakajima","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2024.03.002_bib112","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and -\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2024.03.002_bib113","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa2304286","article-title":"Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH","volume":"389","author":"Loomba","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2024.03.002_bib114","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MOL.0b013e3282f9b54d","article-title":"Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism","volume":"19","author":"Flowers","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.livres.2024.03.002_bib115","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1074\/jbc.M110.138115","article-title":"Role of peroxisome proliferator-activated receptor {delta}\/{beta} in hepatic metabolic regulation","volume":"286","author":"Liu","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2024.03.002_bib116","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molmet.2017.12.008","article-title":"Hepatic regulation of VLDL receptor by PPAR\u03b2\/\u03b4 and FGF21 modulates non-alcoholic fatty liver disease","volume":"8","author":"Zarei","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib117","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2005.08.070","article-title":"Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice","volume":"336","author":"Inoue","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.livres.2024.03.002_bib118","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1096\/fj.10-173716","article-title":"Role for PPAR\u03b3 in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts","volume":"25","author":"Mor\u00e1n-Salvador","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.livres.2024.03.002_bib119","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI200317223","article-title":"Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes","volume":"111","author":"Matsusue","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2024.03.002_bib120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/00365520802530861","article-title":"Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice","volume":"44","author":"Nan","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.livres.2024.03.002_bib121","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1476-5926-2-S1-S7","article-title":"PPAR gamma and hepatic stellate cells","volume":"Suppl 1","author":"Hazra","year":"2004","journal-title":"Comp Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib122","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/liv.15441","article-title":"Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice","volume":"42","author":"Ni","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2024.03.002_bib123","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13105-020-00777-7","article-title":"Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-\u03b21\/Smad signaling pathway","volume":"77","author":"Ni","year":"2021","journal-title":"J\u00a0Physiol Biochem"},{"key":"10.1016\/j.livres.2024.03.002_bib124","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10238-016-0438-x","article-title":"Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings","volume":"17","author":"Panebianco","year":"2017","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.livres.2024.03.002_bib125","article-title":"Effect of modulation of PPAR-\u03b3 activity on Kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2024.03.002_bib126","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2013.06.023","article-title":"Cell-specific PPAR\u03b3 deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells","volume":"59","author":"Mor\u00e1n-Salvador","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib127","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/jgh.15025","article-title":"Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4\/NF-\u03baB signaling pathway","volume":"35","author":"Wu","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib128","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature05894","article-title":"Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance","volume":"447","author":"Odegaard","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.livres.2024.03.002_bib129","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/jc.2010-2129","article-title":"Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction","volume":"96","author":"Pettinelli","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jhep.2019.10.023","article-title":"Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase IIb study","volume":"72","author":"Harrison","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib131","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2024.03.002_bib132","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2024.03.002_bib133","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.31843","article-title":"Saroglitazar, a PPAR-\u03b1\/\u03b3 agonist, for treatment of NAFLD: a randomized controlled double-blind phase 2 trial","volume":"74","author":"Gawrieh","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib134","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A\u00a0randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2024.03.002_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166133","article-title":"FXR in liver physiology: multiple faces to regulate liver metabolism","volume":"1867","author":"Panzitt","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.livres.2024.03.002_bib136","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.livres.2021.08.002","article-title":"Bile acid metabolism and bile acid receptor signaling in metabolic diseases and therapy","volume":"5","author":"Chiang","year":"2021","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2024.03.002_bib137","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s11095-013-0986-7","article-title":"Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance","volume":"30","author":"Ma","year":"2013","journal-title":"Pharm Res"},{"key":"10.1016\/j.livres.2024.03.002_bib138","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/mol.117.111047","article-title":"Effects of farnesoid X receptor activation on arachidonic acid metabolism, NF-kB signaling, and hepatic inflammation","volume":"94","author":"Gai","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.livres.2024.03.002_bib139","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.03.025","article-title":"Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis","volume":"51","author":"Zhang","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib140","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib141","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2024.03.002_bib142","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor","volume":"17","author":"Pineda Torra","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.livres.2024.03.002_bib143","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/hep.32577","article-title":"Hepatocellular cystathionine \u03b3 lyase\/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor","volume":"76","author":"Xu","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib144","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2353\/ajpath.2009.090114","article-title":"Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts","volume":"175","author":"Fickert","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2024.03.002_bib145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/164_2019_228","article-title":"Pharmacologic modulation of bile acid-FXR-FGF15\/FGF19 pathway for the treatment of nonalcoholic steatohepatitis","volume":"256","author":"Schumacher","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.livres.2024.03.002_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.07.013","article-title":"Salvianolic acid B blocks hepatic stellate cell activation via FGF19\/FGFR4 signaling","volume":"20","author":"Tian","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib147","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2024.03.002_bib148","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jhep.2023.07.014","article-title":"Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis","volume":"79","author":"Sanyal","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2024.03.002_bib149","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41591-022-02200-8","article-title":"Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a\/b trial","volume":"29","author":"Sanyal","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2024.03.002_bib150","first-page":"1","article-title":"Activation of liver X receptors (LXRs) increases sphingolipid biosynthesis in hepatic cells","volume":"2","author":"Sherwin","year":"2016","journal-title":"Matters Select"},{"key":"10.1016\/j.livres.2024.03.002_bib151","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.3390\/ijms20205045","article-title":"Liver X receptors regulate cholesterol metabolism and immunity in hepatic nonparenchymal cells","volume":"20","author":"Endo-Umeda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2024.03.002_bib152","first-page":"69","article-title":"Liver X receptors bridge hepatic lipid metabolism and inflammation","volume":"13","author":"Liu","year":"2012","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.livres.2024.03.002_bib153","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/15548627.2016.1235123","article-title":"Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H\/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cells","volume":"13","author":"Sinha","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.livres.2024.03.002_bib154","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1101\/gad.545110","article-title":"GPS2-dependent corepressor\/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response","volume":"24","author":"Venteclef","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.livres.2024.03.002_bib155","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08009","article-title":"LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling","volume":"4","author":"Ito","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.livres.2024.03.002_bib156","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/en.2017-03141","article-title":"Dysregulation of Kupffer cells\/macrophages and natural killer T cells in steatohepatitis in LXR\u03b1 knockout male mice","volume":"159","author":"Endo-Umeda","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.livres.2024.03.002_bib157","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1053\/j.gastro.2010.11.053","article-title":"Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease","volume":"140","author":"Beaven","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2024.03.002_bib158","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/cells12091292","article-title":"Targeting liver X receptors for the treatment of non-alcoholic fatty liver disease","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.livres.2024.03.002_bib159","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)80900-9","article-title":"An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway","volume":"92","author":"Kliewer","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.livres.2024.03.002_bib160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/FPC.0b013e3282f706e0","article-title":"Sterol regulatory element binding protein 1 interacts with pregnane X receptor and constitutive androstane receptor and represses their target genes","volume":"18","author":"Roth","year":"2008","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.livres.2024.03.002_bib161","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","article-title":"Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis","volume":"134","author":"Zhou","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2024.03.002_bib162","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcp.2017.07.019","article-title":"Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression","volume":"142","author":"Zhao","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.livres.2024.03.002_bib163","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00204-014-1348-x","article-title":"Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms","volume":"89","author":"Bitter","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.livres.2024.03.002_bib164","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/cells11010061","article-title":"The nuclear receptor PXR in chronic liver disease","volume":"11","author":"Sayaf","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.livres.2024.03.002_bib165","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.1198125","article-title":"A\u00a0circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism","volume":"331","author":"Feng","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.livres.2024.03.002_bib166","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.aab3021","article-title":"GENE REGULATION. Discrete functions of nuclear receptor Rev-erb\u03b1 couple metabolism to the clock","volume":"348","author":"Zhang","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.livres.2024.03.002_bib167","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature11030","article-title":"Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists","volume":"485","author":"Solt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.livres.2024.03.002_bib168","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/s41401-022-00883-w","article-title":"The role of REV-ERB in NASH","volume":"43","author":"Griffett","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.livres.2024.03.002_bib169","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236000","article-title":"REV-ERB agonism improves liver pathology in a mouse model of NASH","volume":"15","author":"Griffett","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2024.03.002_bib170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3132\/dvdr.2008.0014","article-title":"The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolism","volume":"5","author":"Duez","year":"2008","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.livres.2024.03.002_bib171","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tem.2012.05.012","article-title":"Action of RORs and their ligands in (patho) physiology","volume":"23","author":"Solt","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib172","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1152\/physiolgenomics.00206.2010","article-title":"Transcriptional profiling reveals a role for RORalpha in regulating gene expression in obesity-associated inflammation and hepatic steatosis","volume":"43","author":"Kang","year":"2011","journal-title":"Physiol Genom"},{"key":"10.1016\/j.livres.2024.03.002_bib173","doi-asserted-by":"crossref","first-page":"18411","DOI":"10.1074\/jbc.M710526200","article-title":"The orphan nuclear receptor, RORalpha, regulates gene expression that controls lipid metabolism: staggerer (SG\/SG) mice are resistant to diet-induced obesity","volume":"283","author":"Lau","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2024.03.002_bib174","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1101\/gad.302323.117","article-title":"The hepatic circadian clock fine-tunes the lipogenic response to feeding through ROR\u03b1\/\u03b3","volume":"31","author":"Zhang","year":"2017","journal-title":"Genes Dev"},{"key":"10.1016\/j.livres.2024.03.002_bib175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41467-017-00215-1","article-title":"ROR\u03b1 controls hepatic lipid homeostasis via negative regulation of PPAR\u03b3 transcriptional network","volume":"8","author":"Kim","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.livres.2024.03.002_bib176","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.celrep.2017.06.017","article-title":"ROR\u03b1 Induces KLF4-mediated M2 polarization in the liver macrophages that protect against nonalcoholic steatohepatitis","volume":"20","author":"Han","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.livres.2024.03.002_bib177","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cmet.2016.03.007","article-title":"The small molecule nobiletin targets the molecular Oscillator to enhance circadian rhythms and protect against metabolic syndrome","volume":"23","author":"He","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib178","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/cb1002762","article-title":"Identification of SR3335 (ML-176): a synthetic ROR\u03b1 selective inverse agonist","volume":"6","author":"Kumar","year":"2011","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.livres.2024.03.002_bib179","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fendo.2019.00206","article-title":"ERR\u03b1 as a Bridge between transcription and function: role in liver metabolism and disease","volume":"10","author":"Xia","year":"2019","journal-title":"Front Endocrinol(Lausanne)"},{"key":"10.1016\/j.livres.2024.03.002_bib180","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam5855","article-title":"Thyroid hormone receptor and ERR\u03b1 coordinately regulate mitochondrial fission, mitophagy, biogenesis, and function","volume":"11","author":"Singh","year":"2018","journal-title":"Sci Signal"},{"key":"10.1016\/j.livres.2024.03.002_bib181","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1128\/MCB.23.22.7947-7956.2003","article-title":"Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha","volume":"23","author":"Luo","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.livres.2024.03.002_bib182","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cmet.2013.03.003","article-title":"Molecular and genetic crosstalks between mTOR and ERR\u03b1 are key determinants of rapamycin-induced nonalcoholic fatty liver","volume":"17","author":"Chaveroux","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2024.03.002_bib183","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1210\/en.2018-00115","article-title":"Divergent role of estrogen-related receptor \u03b1 in lipid- and fasting-induced hepatic steatosis in mice","volume":"159","author":"B\u2019chir","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.livres.2024.03.002_bib184","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.7150\/thno.47037","article-title":"Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD\/NASH development","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.livres.2024.03.002_bib185","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.ajpath.2021.04.007","article-title":"Inhibition of estrogen-related receptor \u03b1 blocks liver steatosis and steatohepatitis and attenuates triglyceride biosynthesis","volume":"191","author":"Chen","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2024.03.002_bib186","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.isci.2018.10.018","article-title":"Binding of drug-activated CAR\/Nr1i3 alters metabolic regulation in the liver","volume":"9","author":"Tian","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.livres.2024.03.002_bib187","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/toxsci\/kfv250","article-title":"Polychlorinated biphenyl-xenobiotic nuclear receptor interactions regulate energy metabolism, behavior, and inflammation in non-alcoholic-steatohepatitis","volume":"149","author":"Wahlang","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.livres.2024.03.002_bib188","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.taap.2016.05.006","article-title":"Activation of the constitutive androstane receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way","volume":"303","author":"Marmugi","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.livres.2024.03.002_bib189","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/cells12081201","article-title":"Steatosis and metabolic disorders associated with synergistic activation of the CAR\/RXR heterodimer by pesticides","volume":"12","author":"Dauwe","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.livres.2024.03.002_bib190","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/carcin\/bgq277","article-title":"Constitutive active\/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis","volume":"32","author":"Takizawa","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.livres.2024.03.002_bib191","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/gut.2006.093260","article-title":"The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis","volume":"56","author":"Yamazaki","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.livres.2024.03.002_bib192","doi-asserted-by":"crossref","first-page":"18831","DOI":"10.1073\/pnas.0909731106","article-title":"Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease","volume":"106","author":"Dong","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2024.03.002_bib193","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep4.1232","article-title":"Hepatic nuclear receptor expression associates with features of histology in pediatric nonalcoholic fatty liver disease","volume":"2","author":"Elbel","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2024.03.002_bib194","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.272.5266.1336","article-title":"An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors","volume":"272","author":"Seol","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.livres.2024.03.002_bib195","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/sj.emboj.7600728","article-title":"Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP","volume":"24","author":"Boulias","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.livres.2024.03.002_bib196","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1124\/mol.114.096313","article-title":"Repression of the nuclear receptor small heterodimer partner by steatotic drugs and in advanced nonalcoholic fatty liver disease","volume":"87","author":"Benet","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.livres.2024.03.002_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104946","article-title":"Transgenic mice lacking FGF15\/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease","volume":"299","author":"Kim","year":"2023","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2024.03.002_bib198","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0021-9258(17)49910-8","article-title":"Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis","volume":"295","author":"Magee","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2024.03.002_bib199","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/oby.20890","article-title":"The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice","volume":"22","author":"Myronovych","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.livres.2024.03.002_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166639","article-title":"Epiberberine regulates lipid synthesis through SHP (NR0B2) to improve non-alcoholic steatohepatitis","volume":"1869","author":"Zhou","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.livres.2024.03.002_bib201","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.1074\/jbc.RA117.001653","article-title":"Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"293","author":"Zou","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2024.03.002_bib202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep.21632","article-title":"Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver","volume":"46","author":"Huang","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib203","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.26225","article-title":"Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis","volume":"57","author":"Bechmann","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib204","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.omtn.2019.10.044","article-title":"Liver activation of hepatocellular nuclear factor-4\u03b1 by small activating RNA rescues dyslipidemia and improves metabolic profile","volume":"19","author":"Huang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.livres.2024.03.002_bib205","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.31773","article-title":"Sirtuin 2 prevents liver steatosis and metabolic disorders by deacetylation of hepatocyte nuclear factor 4\u03b1","volume":"74","author":"Ren","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154307","article-title":"Defects in high density lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of hepatocyte nuclear factor 4A","volume":"110","author":"Thymiakou","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.livres.2024.03.002_bib207","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2337\/db21-0181","article-title":"Hepatocytic activating transcription factor 3 protects against steatohepatitis via hepatocyte nuclear factor 4\u03b1","volume":"70","author":"Xu","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.livres.2024.03.002_bib208","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/hep.31604","article-title":"Hepatocyte nuclear factor 4\u03b1 prevents the steatosis-to-NASH progression by regulating p53 and bile acid signaling (in mice)","volume":"73","author":"Xu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib209","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1002\/jcp.26270","article-title":"High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4\u03b1 and leads to hepatic steatosis in mice","volume":"233","author":"Yu","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.livres.2024.03.002_bib210","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.chembiol.2012.05.014","article-title":"HNF4\u03b1 antagonists discovered by a high-throughput screen for modulators of the human insulin promoter","volume":"19","author":"Kiselyuk","year":"2012","journal-title":"Chem Biol"},{"key":"10.1016\/j.livres.2024.03.002_bib211","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.32326","article-title":"Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans","volume":"76","author":"Gunewardena","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.03.002_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166145","article-title":"Emerging functions of the nuclear receptor LRH-1 in liver physiology and pathology","volume":"1867","author":"Sun","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.livres.2024.03.002_bib213","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96151","article-title":"LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity","volume":"3","author":"Miranda","year":"2018","journal-title":"JCI Insight"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568424000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568424000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T22:55:36Z","timestamp":1712616936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568424000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":213,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2542568424000060"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2024.03.002","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting nuclear receptors for NASH\/MASH: From bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2024.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}